We are live on ! Find out more
Bank Julius Baer & Co

Bank Julius Baer & Co Portfolio holdings

AUM $33.2B
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+10.19%
1 Year Est. Return
+25.01%
3 Year Est. Return
+91.4%
5 Year Est. Return
+116.23%
10 Year Est. Return
AUM
$18.7B
AUM Growth
+$2.61B
Cap. Flow
+$602M
Cap. Flow %
3.22%
Top 10 Hldgs %
36.92%
Holding
923
New
116
Increased
301
Reduced
299
Closed
97

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$79.7M
2
ROP icon
Roper Technologies
ROP
+$53M
3
WFC icon
Wells Fargo
WFC
+$44.6M
4
EA
Electronic Arts
EA
+$41.3M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$33.4M

Sector Composition

Rank Sector Weight
1 Technology 26.31%
2 Healthcare 15.2%
3 Financials 12.74%
4 Communication Services 8.59%
5 Consumer Discretionary 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDK
551
DELISTED
CDK Global, Inc.
CDK
$167K ﹤0.01%
4,000
ATO icon
552
Atmos Energy
ATO
$28.8B
$166K ﹤0.01%
1,584
-13
-0.8% -$1.23K
BEN icon
553
Franklin Resources
BEN
$17.2B
$166K ﹤0.01%
4,943
-28,397
-85% -$935K
ERIE icon
554
Erie Indemnity
ERIE
$13.2B
$166K ﹤0.01%
864
+52
+6% +$10.4K
HRL icon
555
Hormel Foods
HRL
$13.8B
$166K ﹤0.01%
3,392
-181
-5% -$7.93K
KDP icon
556
Keurig Dr Pepper
KDP
$40.8B
$166K ﹤0.01%
4,510
-92
-2% -$3.24K
MKC icon
557
McCormick & Company Non-Voting
MKC
$14.2B
$166K ﹤0.01%
1,715
-42
-2% -$3.58K
TYL icon
558
Tyler Technologies
TYL
$12.8B
$166K ﹤0.01%
308
-29
-9% -$15K
AEE icon
559
Ameren
AEE
$30.1B
$165K ﹤0.01%
1,858
-46
-2% -$3.91K
ED icon
560
Consolidated Edison
ED
$39.9B
$165K ﹤0.01%
1,931
-156
-7% -$12.3K
BIO icon
561
Bio-Rad Laboratories Class A
BIO
$9.42B
$164K ﹤0.01%
217
-1,518
-87% -$1.14M
MASI
562
DELISTED
Masimo
MASI
$164K ﹤0.01%
559
-53
-9% -$15.1K
CAG icon
563
Conagra Brands
CAG
$7.23B
$163K ﹤0.01%
4,774
BKI
564
DELISTED
Black Knight, Inc. Common Stock
BKI
$163K ﹤0.01%
1,968
-98
-5% -$7.31K
GH icon
565
Guardant Health
GH
$22.6B
$162K ﹤0.01%
1,620
+620
+62% +$64.1K
CMI icon
566
Cummins
CMI
$88.7B
$160K ﹤0.01%
734
-21
-3% -$4.79K
NUE icon
567
Nucor
NUE
$62.1B
$159K ﹤0.01%
1,396
-22
-2% -$2.4K
EWT icon
568
iShares MSCI Taiwan ETF
EWT
$11.1B
$157K ﹤0.01%
2,351
-2,081
-47% -$134K
CTXS
569
DELISTED
Citrix Systems Inc
CTXS
$157K ﹤0.01%
1,657
+6
+0.4% +$548
ILF icon
570
iShares Latin America 40 ETF
ILF
$3.83B
$156K ﹤0.01%
6,660
LEVI icon
571
Levi Strauss
LEVI
$9.39B
$153K ﹤0.01%
+6,100
New +$157K
FULC icon
572
Fulcrum Therapeutics
FULC
$297M
$150K ﹤0.01%
8,500
ROBO icon
573
ROBO Global Robotics & Automation Index ETF
ROBO
$2.11B
$144K ﹤0.01%
2,056
HBI
574
DELISTED
Hanesbrands
HBI
$142K ﹤0.01%
8,500
WAT icon
575
Waters Corp
WAT
$39.9B
$140K ﹤0.01%
375

Similar funds

Bank Julius Baer & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Bank Julius Baer & Co held 923 positions worth $18.7B, up 16% from $16.1B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Bank Julius Baer & Co deployed $602M of net new capital in Q4 2021, opening 116 new positions and adding to 301 existing holdings. Its largest new stake was iShares US Treasury Bond ETF: 785,741 shares worth $21M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Merck, an estimated $79.7M trimmed.

  • Bank Julius Baer & Co's largest Q4 2021 buy was iShares US Treasury Bond ETF: 785,741 shares worth $21M.
  • Bank Julius Baer & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $123M increase.
  • Bank Julius Baer & Co's biggest Q4 2021 reduction was Merck, cutting an estimated $79.7M.
  • Bank Julius Baer & Co fully exited Encompass Health in Q4 2021, selling an estimated $32.7M.
  • Bank Julius Baer & Co's ten largest holdings make up 37% of its $18.7B portfolio in Q4 2021.
  • Bank Julius Baer & Co opened 116 new positions and closed 97 in Q4 2021.
  • Bank Julius Baer & Co's portfolio value rose 16% quarter-over-quarter to $18.7B.

Based on Bank Julius Baer & Co's 13F filing for Q4 2021, filed 15 Feb 2022.